The dark side of the NGF family: neurotrophins in neoplasias.
about
TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behaviorBiological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspectiveSingle cycle structure-based humanization of an anti-nerve growth factor therapeutic antibodyIndividual and co-expression patterns of nerve growth factor and heme oxygenase-1 predict shorter survival of gastric carcinoma patients.Heat shock protein 90 inhibition depletes TrkA levels and signaling in human acute leukemia cells.NGF blockade at early times during bone cancer development attenuates bone destruction and increases limb useExpression of nerve growth factor and heme oxygenase-1 predict poor survival of breast carcinoma patients.NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling.Nerve growth factor links oral cancer progression, pain, and cachexia.Neurotrophic factors in neurodegeneration.Pathophysiological mechanisms for actions of the neurotrophins.ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.Nerve growth factor in cancer cell death and survival.Nerve growth factor from cobra venom inhibits the growth of Ehrlich tumor in mice.Nerve growth factor signaling in prostate health and disease.Nerve growth factor modulates the tumor cells migration in ovarian cancer through the WNT/β-catenin pathway.Neurotrophins in lung health and disease.Immunohistochemical profile of neurotrophins and MIB-1 in jugulotympanic paragangliomas: prognostic value and review of the literature.Human gallbladder carcinoma: Role of neurotrophins, MIB-1, CD34 and CA15-3.Effects of castration on the expression of the NGF and TrkA in the vas deferens and accessory male genital glands of the rat.Role of the autonomic nervous system in tumorigenesis and metastasisProlyl isomerase Pin1 and neurotrophins: a loop that may determine the fate of cells in cancer and neurodegeneration.Natural antibodies against nerve growth factor inhibit in vitro prostate cancer cell metastasis.Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.Intrinsic signaling functions of the beta4 integrin intracellular domain.Hypomethylation of CNTFRα is associated with proliferation and poor prognosis in lower grade gliomas.Integrative analysis of cancer-related signaling pathways.Functional characterization of NTRK1 mutations identified in melanoma.Diagnostic value of neurotrophin expression in malignant pleural effusions.The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages.Oral carcinoma with perineural invasion has higher nerve growth factor expression and worse prognosis.Cross-talk between androgen receptor and nerve growth factor receptor in prostate cancer cells: implications for a new therapeutic approach.Chromosomal breaks at FRA18C: association with reduced DOK6 expression, altered oncogenic signaling and increased gastric cancer survival.
P2860
Q24299955-59EFBC85-E919-4E16-BFB5-3333211F1646Q24658389-E6C8A291-2CC0-413E-870A-104B31AFA7ECQ28731515-C521E0E3-568F-448C-8123-01510C5D3E1BQ33876439-7CD1ED7B-C744-4D3D-AE4E-B83ECEB14A37Q34433002-E37D81F3-F222-4CF5-9497-663284CCBE9BQ34617294-A267D20F-08A5-4FA5-BDE6-130A27FE068DQ35030367-93BBB508-6B4C-42FA-B542-BEB0C3A63546Q35588883-2736C69F-2A08-49A1-9D83-4B46D1C94CC4Q36031474-25F57962-B244-44AC-8F96-E66EB583BE9AQ36654492-65112A6A-5BE5-4CEC-9B15-A2FBF1FA75A7Q36654505-BDA1D6E2-5441-4753-AAF6-2CC6C327E8D0Q37021547-826D672A-4679-4E8D-83E8-18797BFF9E9BQ37129797-C8BBE3A4-98CD-4B76-8937-47BE58B658CDQ37670005-1CD4CB7E-ED19-4442-A121-C5A09D61D3EEQ37694590-37BD7CB3-D620-4DA6-AC02-AD85CD71CF7AQ37697114-6CB6A94C-A646-4679-B5A2-23213319FFE7Q37762836-3200E2E8-C17E-49DA-9DFA-831C231F1258Q38002975-DD35D529-BBD8-42B2-AA47-42634F67C8E3Q38312791-71C9AF7E-BCF8-40C9-A446-00C639718FB6Q38313698-95C5E1F7-B766-4166-909D-7C92D8BE6EE6Q38866767-2CEF505A-5B68-47BA-95F2-C7686BF7B471Q39137665-CCBB9D71-1904-4BF5-A86E-8B65674908CEQ39639830-4C1BA2CF-31B3-41D8-9124-20B47D883DDFQ39911338-12267064-9C75-4501-A32B-4B34903B24FAQ40091012-7FC1292D-E14C-424F-9CC2-88BEE2111097Q41204421-D9DD60C2-9EF2-4CEB-928A-0080DEF3D525Q41458214-082FA57A-3573-4D3C-A2F9-9E02FD70D608Q42800660-5B7267F1-1959-42E2-9023-8464AC5B61CBQ43078765-0F55A271-ABBB-4DF5-BE67-938224E5546CQ45720263-9F160754-B87B-46FA-95FB-ECD6DDDB9754Q46014455-94F88BFD-3C97-4C40-B415-2021D8AB0508Q52659237-5020DD81-26E8-44CF-A603-02B63082A74EQ54976924-BE000D48-BC67-4D94-838D-711138EA9EE5
P2860
The dark side of the NGF family: neurotrophins in neoplasias.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The dark side of the NGF family: neurotrophins in neoplasias.
@ast
The dark side of the NGF family: neurotrophins in neoplasias.
@en
type
label
The dark side of the NGF family: neurotrophins in neoplasias.
@ast
The dark side of the NGF family: neurotrophins in neoplasias.
@en
prefLabel
The dark side of the NGF family: neurotrophins in neoplasias.
@ast
The dark side of the NGF family: neurotrophins in neoplasias.
@en
P2093
P2860
P1433
P1476
The dark side of the NGF family: neurotrophins in neoplasias.
@en
P2093
Alex Krüttgen
Imke Schneider
Joachim Weis
P2860
P304
P356
10.1111/J.1750-3639.2006.00037.X
P577
2006-10-01T00:00:00Z